| Product Code: ETC10079506 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Neurodegenerative Disease Treatment Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Neurodegenerative Disease Treatment Market - Industry Life Cycle |
3.4 Vietnam Neurodegenerative Disease Treatment Market - Porter's Five Forces |
3.5 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Drug Type:, 2021 & 2031F |
3.7 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Route of Administration:, 2021 & 2031F |
3.8 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume Share, By Distribution Channel:, 2021 & 2031F |
4 Vietnam Neurodegenerative Disease Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurodegenerative diseases in Vietnam |
4.2.2 Growing awareness and diagnosis rates for neurological disorders |
4.2.3 Advances in medical technology and treatment options for neurodegenerative diseases |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in remote areas |
4.3.2 High treatment costs associated with neurodegenerative disease management |
4.3.3 Lack of healthcare infrastructure and skilled professionals in neurology |
5 Vietnam Neurodegenerative Disease Treatment Market Trends |
6 Vietnam Neurodegenerative Disease Treatment Market, By Types |
6.1 Vietnam Neurodegenerative Disease Treatment Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Multiple Sclerosis, 2021- 2031F |
6.1.4 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Parkinsons Disease, 2021- 2031F |
6.1.5 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Alzheimers Disease, 2021- 2031F |
6.1.6 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Spinal Muscular Atrophy (SMA), 2021- 2031F |
6.1.7 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Huntingtons Disease, 2021- 2031F |
6.1.8 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Vietnam Neurodegenerative Disease Treatment Market, By Drug Type: |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By N-methyl-D-aspartate Receptor Antagonists, 2021- 2031F |
6.2.3 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Selective Serotonin Reuptake Inhibitors, 2021- 2031F |
6.2.4 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Dopamine Inhibitors, 2021- 2031F |
6.2.5 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Vietnam Neurodegenerative Disease Treatment Market, By Route of Administration: |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.4 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Vietnam Neurodegenerative Disease Treatment Market, By Distribution Channel: |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Vietnam Neurodegenerative Disease Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Vietnam Neurodegenerative Disease Treatment Market Import-Export Trade Statistics |
7.1 Vietnam Neurodegenerative Disease Treatment Market Export to Major Countries |
7.2 Vietnam Neurodegenerative Disease Treatment Market Imports from Major Countries |
8 Vietnam Neurodegenerative Disease Treatment Market Key Performance Indicators |
8.1 Average wait time for neurodegenerative disease treatment appointments |
8.2 Number of neurologists per capita in Vietnam |
8.3 Adoption rate of new neurodegenerative disease treatment technologies |
8.4 Patient satisfaction with neurodegenerative disease treatment services |
8.5 Percentage of population covered by health insurance for neurology treatments |
9 Vietnam Neurodegenerative Disease Treatment Market - Opportunity Assessment |
9.1 Vietnam Neurodegenerative Disease Treatment Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Vietnam Neurodegenerative Disease Treatment Market Opportunity Assessment, By Drug Type:, 2021 & 2031F |
9.3 Vietnam Neurodegenerative Disease Treatment Market Opportunity Assessment, By Route of Administration:, 2021 & 2031F |
9.4 Vietnam Neurodegenerative Disease Treatment Market Opportunity Assessment, By Distribution Channel:, 2021 & 2031F |
10 Vietnam Neurodegenerative Disease Treatment Market - Competitive Landscape |
10.1 Vietnam Neurodegenerative Disease Treatment Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Neurodegenerative Disease Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here